Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD) dubbed HG202, developed…
Continue Reading
The following is a guest article by Bruno Kurtic, Co-Founder, President, and CEO at Bedrock Security
It’s becoming increasingly evident that the U.S. BIOSECURE Act will soon become the law of the land. The U.S….
A public-private national project in India has introduced what could be the country’s first comprehensive cancer multi-omics database fifteen years after its founding.The Indian Cancer Genome Atlas (ICGA) focuses on studying cancer biology specific…
Continue Reading
Health tech company SEQSTER and consumer engagement platform PatientsLikeMe have partnered to advance clinical research and engage patients, the companies announced Thursday.
San Diego, California-based SEQSTER is a company focused on breaking down healthcare data…
Continue Reading
What You Should Know:
– Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Ultima Genomics to utilize its UG 100TM sequencing solution and ppmSeqTM technology to…
Continue Reading
Molecular classification, particularly microsatellite instability-high (MSI-H), has gained attention for immunotherapy in endometrial cancer (EC). MSI-H is associated with DNA mismatch repair defects and is a crucial treatment predictor. The NCCN guidelines recommend pembrolizumab…
Continue Reading
By Shania Kennedy
May 29, 2024 – A research team from Pennsylvania State University has developed an AI model to gain insight into how gene expression impacts autoimmune disease risk, according to a study published recently…
Continue Reading
AI-enabled protein design company Profluent has leveraged artificial intelligence to design an open-source gene editor called OpenCRISPR-1, demonstrating the technology can be used to create molecules with the power to edit human DNA.Clustered Regularly…
Continue Reading
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer treatment drugs using individual…
Continue Reading
Funding worth A$6.5 million ($4 million) has been awarded to four genomics-focused research projects led by researchers from the University of Melbourne.These include a project that will establish a patient dataset of inherited retinal…
Continue Reading
